相关实验视频
Updated: Jun 24, 2025

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
14.6K
在患有癌症的年轻患者中,诊断的时间
Lena E Winestone1,2, Jennifer J Wilkes3,4, Diane Puccetti5
1Division of Allergy, Immunology, and BMT, University of California, San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Pediatric blood & cancer
|June 12, 2024
概括
儿科,青少年和年轻成人癌症的诊断延迟是常见的. 诊断的时间因癌症类型,年龄和性别而异,女性和年轻/老年患者经历了更长的延迟.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 流行病学 流行病学
背景情况:
- 影响儿科,青少年和年轻成人癌症诊断延迟的社会人口统计学和临床因素仍然不清楚.
- 了解这些因素对于及时诊断癌症和改善患者治疗结果至关重要.
研究的目的:
- 调查与儿科,青少年和年轻成人癌症诊断延迟相关的社会人口统计学和临床因素.
- 确定从症状发作到诊断的时间较长的患者子组.
主要方法:
- 分析了47296名商业保险患者 (0-39岁) 的非识别索赔数据,这些患者被诊断患有10种常见癌症 (2001-2017).
- 从第一次症状接触到癌症诊断的诊断时间的计算.
- 多变量后勤回归用于识别与超过3个月的延迟相关的因素.
主要成果:
- 87%的患者在诊断之前出现了症状.
- 中枢神经系统 (CNS) 瘤的症状呈现率最高 (93%).
- 甲状腺癌和宫癌的诊断时间中位数最长 (分别为105天和104天). 女性和年龄范围极端的患者经历了更长的延迟.
结论:
- 在商业保险人群中,癌症诊断的时间因癌症类型,患者年龄和性别而异.
- 需要进一步的研究来阐明导致诊断延迟的患者,提供者和卫生系统因素,特别是在非常年幼的儿童和年轻人中.
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

